/MNZO

MNZO Stock - Manzo Pharmaceuticals, Inc.

Q: What is the analyst price target for MNZO?

Analyst price target information is not currently available for MNZO.

Q: What is MNZO's market cap?

Market capitalization information is not currently available for MNZO.

Financial Services|Shell Companies|OTC

$0.00+0.00%

+$0.00 (+0.00%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.00

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for MNZO

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2003

FY2004

FY2014

FY2015

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-44.70

52W High$0.00

52W Low$0.00

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2015	FY2014	FY2004	FY2003
Revenue	$2,014	$548	$3.07M	$3.00M
Gross Profit	$793	$548	$20,966	$755,889
Gross Margin	39.4%	100.0%	0.7%	25.2%
Operating Income	$793	$-245,813	$-3,197,572	$-3,247,689
Net Income	$-36,244	$-989,106	$-4,150,371	$-3,953,041
Net Margin	-1799.6%	-180493.8%	-135.2%	-131.6%
EPS	$-0.00	$-0.00	$-1.20	$-1.20

Company Overview

Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014. Manzo Pharmaceuticals, Inc. is based in Milford, Pennsylvania.

Visit Website

Frequently Asked Questions about MNZO

What is MNZO's current stock price?

Manzo Pharmaceuticals, Inc. (MNZO) is currently trading at $0.00 per share. The stock has moved +0.00% today.

What is the analyst price target for MNZO?

No analyst price targets are currently available for this stock.

What sector is Manzo Pharmaceuticals, Inc. in?

Manzo Pharmaceuticals, Inc. operates in the Financial Services sector, specifically within the Shell Companies industry. The company is traded on the OTC exchange.

What is MNZO's market cap?

Manzo Pharmaceuticals, Inc. has a market capitalization of $0.00 billion, making it a small-cap company.

Does MNZO pay dividends?

No, Manzo Pharmaceuticals, Inc. does not currently pay a dividend to shareholders.